Remission, relapse, intestinal healing and repair

Inflammatory Bowel Disease: From Bench to Bedside

Volumn , Issue , 2006, Pages 197-209

  Göke, Michael N ^a   Podolsky, Daniel K ^b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 25844468636     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25808-6_9     Document Type: Chapter

References (171)

1. Silen W. Gastric mucosal defense and repair. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract, 2nd edn. New York: Raven Press, 1987: 1055-69
2. Goke M, Podolsky DK. Regulation of the mucosal epithehal barrier. BailHere's Clin Gastroenterol 1996; 10: 393-405
3. Wilson AJ, Gibson PR. Epithelial migration in the colon: Filling in the gaps. Clin Sci 1997; 93: 97-108
4. Gumbiner BM. Cell adhesion: The molecular basis of tisuue architecture and morphogenesis. Cell 1996; 84: 345-57
5. Mitchison TJ, Cramer LP. Actin-based cell motility and cell locomotion. Cell 1996; 84: 371-9
6. McCormack SA, Viar MJ, Johnson LR. Migration of IEC-6 cells: A model for mucosal healing. Am J Physiol 1992; 263: G426-35
7. Yuan Q, Viar MJ, Ray RM, Johnson LR. Putrescine does not support the migration and growth of IEC-6 cells. Am J Physiol 2000; 278: G49-56
8. Zushi S, Shinomura Y, Kiyohara T et al Role of prostaglandins in intestinal epithelial restitution stimulated by growth factors. Am J Physiol 1996; 270: G757-62
9. Blikslager AT, Roberts MC, Rhoads JM, Argenzio RA. Prostaglandins 12 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest 1997; 100: 1928-33
10. Wilson AJ, Gibson PR. Short-chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology 1997; 113:487-96
11. Ruthig DJ, Meckling-Gill KA. Both (n-3) and (n-6) fatty acids stimulate wound healing in the rat intestinal epithelial cell line, IEC-6. J Nutr 1999; 129: 1791-8
12. Horie-Sakata K, Shimada T, Hiraishi H, Terano A. Role of cyclooxygenase 2 in hepatocyte growth factor-mediated gastric epithelial restitution. J Clin Gastroenterol 1998; 27(Suppl. 1): S40-6
13. Morteau O, Morham SG, Sellon R et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 2000; 105: 469-78
14. Santos MP, McCormack SA, Guo Z et al. Rho proteins play a critical role in cell migration during the early phase of mucosal restitution. J Clin Invest 1997; 100: 216-25
15. Koyama S, Podolsky DK. Differential expression of transforming growth factors a and P in rat intestinal epithelial cells. J Clin Invest 1989; 83: 1768-73
16. Kurokawa M, Lynch K, Podolsky DK. Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor p inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun 1987; 42: 775-82
17. Podolsky DK, Babyatsky MW. Growth and development of the gastrointestinal tract. In: Yamada T, ed. Textbook of Gastroenterology, 2nd edn. Philadelphia: JB Lippincott, 1995: 546-77
18. Suemori S, Ciacci C, Podolsky DK. Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest 1991; 87: 2216-221
19. Ohneda K, Ulshen MH, Fuller CR, D'Ercole AJ, Lund PK. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 1997; 112:444-54
20. Guo YS, Narayan S, Yallampalli C, Singh P. Characterization of insulin-like growth factor I receptors in human colon cancer. Gastroenterology 1992; 102: 1101-8
21. Park JHY, McCusker RH, Vanderhoof JA, Mohammadpour H, Harty RF, MacDonald RG. Secretion of insulinlike growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: Implications for autocrine growth regulation. Endocrinology 1992; 131: 1359-68
22. Steeb CB, Trahair JF, Read LC. Administration of insulinlike growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats. Gut 1995; 37: 630-8
23. Dignass AU, Lynch-Devaney K, Podolsky DK. Hepatocyte growth factor/scatter factor modulates intestinal epithelial proliferation and migration. Biochem Biophys Res Commun 1994; 202: 701-9
24. Fukamachi H, Ichinose M, Tsukada S et al. Hepatocyte growth factor region specifically stimulates gastrointestinal epithelial growth in primary culture. Biochem Biophys Res Commun 1994; 205: 1445-51
25. Goke M, Kanai M, Podolsky DK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol 1998; 274: G809-18
26. Dignass AU, Tsunekawa S, Podolsky DK. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 1994; 106: 1254-62
27. Housley RM, Morris CF, Boyle W et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994; 94: 1764-77
28. Potten CS, Owen G, Hewitt D et al. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in-vivo administration of growth factors. Gut 1995; 36: 864-73
29. Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflam Bowel Dis 1999; 5: 44-60
30. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 1997; 273: E77-84
31. Brubaker PL, Izzo A, Hill M, Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol 1997; 272: G559-63
32. Xiao Q, Boushey RP, Cino M, Drucker DJ, Brubaker PL. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1057-63
33. Boushey RP, Yusta B, Drucker DJ. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol 1999; 277: E937-47
34. Gokc M, Kanai M, Podolsky DK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol 1998; 274: G809-18
35. Simmons JG, Pucilowska JB, Lund PK. Autocrine and paracrine actions of intestinal fibroblast-Derived insulin-like growth factors. Am J Physiol 1999; 276: G817-27
36. Kaiser GC, Polk DB. Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. Gastroenterology 1997;112: 1231-40
37. Ciacci C, Lind SE, Podolsky DK. Transforming growth factor p regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology 1993; 105: 93-101
38. Dignass AU, Podolsky DK. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor p. Gastroenterology 1993; 105: 1323-32
39. Planchon SM, Martins CAP, Guerrant RL, Roche JK. Regulation of intestinal epithelial barrier function by TGFP,. J Immunol 1994; 153:5730-9
40. Hofímann P, Zeeh JM, Lakshmanan J et al. Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats. Gut 1997; 41: 195-202
41. Sottili M, Sternini C, Reinshagen M et al. Up-regulation of transforming growth factor alpha binding sites in experimental rabbit colitis. Gastroenterology 1995; 109: 24-31
42. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996; 110:975-84
43. Egger B, Procaccino F, Lakshmanan J et al. Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology 1997; 113:825-32
44. Egger B, Carey HV, Procaccino F et al. Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut 1998; 43: 64-70
45. Filipe MI, Osborn M, Linehan J, Sanidas E, Brito MJ, Jankowski J. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer 1995;71:30-6
46. Sharp R, Babyatsky MW, Takagi H et al. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development 1995; 121: 149-61
47. Messa C, Russo F, Caruso MG, DiLeo A. EGF, TGFoclpha, and EGF-R in human coloreet al adenocarcinoma. Acta Oncol 1998; 37: 285-9
48. Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108: 564-80
49. Chowdhury A, Fukuda R, Fukumoto S. Growth factor mRNA expression in normal coloreet al mucosa and in uninvolved mucosa from ulcerative colitis patients. J Gastroenterol 1996; 31: 353-60
50. Wright NA, Pike CM, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82-5
51. Bragg LE, Hollingsed TC, Thompson JS. Urogastrone reduces gut atrophy during parenteral alimentation. J Parenter Enteral Nutr 1990; 14: 283-6
52. Ardawi MS. Effects of epidermal growth factor and glutamine-supplemented parenteral nutrition on the small bowel of septic rats. Clin Sci 1992; 82: 573-80
53. Petschow BW, Carter DL, Hutton GD Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats. J Pediatr Gastroenterol Nutr 1993; 17:49-58
54. Procaccino F, Reinshagen M, Hoffmann P et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 1994; 107: 12-17
55. Luck MS, Bass P. Effect of epidermal growth factor on experimental colitis in the rat. J Pharmacol ExpTher 1993; 264: 984-90
56. Meijssen MA, Brandwein SL, Reinecker HC, Bhan AK, Podolsky DK Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-Deficient mice. Am J Physiol 1998; 274: G472-9
57. Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359: 693-9
58. Ncurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-peta-mediated oral tolerance. J Exp Med 1996; 183: 2605-16
59. Beck PL, Xavier RJ, Rosenberg I, Podolsky DK. Intestinal epithelial cell expression of TGF-P dominant negative receptor II (DNRII) results in decreased wound healing in vitro and increased susceptibility to colonic injury in vivo. Gastroenterology 2000; 118: A4843
60. Ohtani H, Kagaya H, Nagura H. Immunohistochemical localization of transforming growth factor-beta. J Gastroenterol Suppl 1995; 30: 76-7
61. Graham MF, Bryson GR, Diegelmann RF. Transforming growth factor Pi selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 1990;99:447-53
62. Mourelle M, Salas A, Guarner F, Crespo E, Garcia-Lafuente A, Malagelada Jr. Stimulation of transforming growth factor-beta-1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 1998; 114: 519-26
63. Finch PW, Pricolo V, Wu A, Finkelstein SD. Increased expression of keratinocyte growth factor messenger RNA associated with inflammatory bowel disease. Gastroenterology 1996; 110:441-51
64. Brauchle M, Madlener M, Wagner AD et al. Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol 1996; 149: 521-9
65. Bajaj-Elliott M, Breese E, Poulsom R, Fairclough PD, MacDonald TT. Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with CD in biopsies and isolated mucosal myofibroblasts. Am J Pathol 1997; 151: 1469-76
66. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science 1994;266: 1253-5
67. Finch PW, Cheng AL. Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut 1999: 45: 848-55
68. Zeeh JM, Procaccino F, Hoffmann P et al. Keratinocyte growth factor ameliorates mucosal injury in an experimental model of colitis in rats. Gastroenterology 1996; 110: 1077-83
69. Egger B, Procaccino F, Sarosi I, Tolmos J, Buchler MW, Eysselein VE. Keratinocyte growth factor ameliorates dextran sodium sulfate coUtis in mice. Dig Dis Sci 1999; 44: 836-44
70. Miceli R, Hubert M, Santiago G et al. Efficacy of keratinocyte growth factor-2 in dextran sulfate sodium-induced murine colitis. J Pharmacol Exp Ther 1999; 290: 464-71
71. Zimmermann EM, Sartor RB, McCall RD, Pardo M, Bender D, Lund PK. Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 1993; 105: 399-409
72. Zeeh JM, Hoffmann P, Sottili M, Eysselein VE, McRoberts JA. Up-regulation of insulinlike growth factor I binding sites in experimental coHtis in rats. Gastroenterology 1995; 108:644-52
73. Howarth GS, Xian CJ, Read LC. Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate soium. Scand J Gastroenterol 1998; 33: 180-90
74. Thomas AG, Holly JM, Taylor F, Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insuHn in childhood crohn's disease. Gut 1993; 34: 944-7
75. Zimmermann EM, Li L, Hou YT, Cannon M, Christman GM, Bitar KN. IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle. Am J Physiol 1997; 273: G875-82
76. Gosh S, Humphreys K, Papachrysostomou M, Ferguson A. Detection of insulin-like growth factor-I and transforming growth factor-beta in whole gut lavage fluid: A novel method of studying intestinal fibrosis. Eur J Gastroenterol Hepatol 1997; 9: 505-8
77. Alexander RJ, Panja A, Kaplan-Liss E, Mayer L, Raicht RF. Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig Dis Sci 1995; 40: 485-94
78. Matsumo M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K. Induction of plasma hepatocyte growth factor in acute colitis of mice. Inflam Res 1997; 46: 166-7
79. Matsumo M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K. Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease. Res Commun Mol Pathol Pharmacol 1997; 97: 25-37
80. Boulton TG, Nye SH, Robins DJ et al ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991; 65: 663-75
81. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses differentially activate c-Jun N-Terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 1995; 270: 29710-17
82. Sanchez I, Hughes RT, Mayer BJ et al. Role of SAPK/ERK kinase-1 in the stress-Activated pathway regulating transcription factor c-Jun. Nature 1994; 72: 794-8
83. Derijard B, Hibi M, Wu IH et al. JNKl. A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-37
84. Kyriakis JM, Banerjee P, Nikolakaki E et al. The stressactivated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-60
85. Rouse J, Cohen P, Trigon S et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 1994; 78: 1027-37
86. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-11
87. Robinson MJ, Cobb MH. Mitogen-Activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180-6
88. Goke M, Kanai M, Lynch-Devaney K, Podolsky DK. Rapid mitogen-Activated protein kinase activation by transforming growth factor alpha in wounded rat intestinal epitheUal cells. Gastroenterology 1998; 114: 697-705
89. Polk DB. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 1998; 114: 493-502
90. Pai R, Ohta M, Itani RM, Safreh IJ, Tarnawski AS. Induction of mitogen-Activated protein kinase signal transduction pathway during gastric ulcer heahng in rats. Gastroenterology 1998; 114: 706-13
91. Sebolt-Leopold JS, Dudley DT, Herrera R et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999; 5: 810-16
92. Dieckgraefe BK, Weems DM. Epithelial injury induces Egr-1 and Fos expression by a pathway involving protein kinase C and ERK. Am J Physiol 1999; 276: G322-30
93. Dieckgraefe BK, Weems DM, Santoro SA, Alpers DH. ERK and p38 MAP kinase pathways are mediators of intestinal epithelial wound-induced signal transduction. Biochem Biophys Res Commun 1997; 233: 389-94
94. Sands BE, Podolsky DK. The trefoil peptide family. Annu Rev Physiol 1996; 58: 253-73
95. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor b-independent pathway. J Clin Invest 1994; 94: 376-83
96. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defence of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-5
97. Liu D, el-Hariry I, Karayiannakis AJ et al. Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 1997; 77: 557-63
98. Hermiston ML, Wong MH, Gordon JI. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system. Genes Dev 1996; 10: 985-96
99. Frisch SM, Francis H. Disruption of epithelial eel-matrix interactions induces apoptosis. J Cefl Biol 1994; 124: 619-26
100. Hague A, Hicks DJ, Bracey TS, Paraskeva C. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: Growth factors protect against c-myc-independent apoptosis. Br J Cancer 1997; 75: 960-8
101. Taupin DR, Kinoshita K, Podolsky DK. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 2000; 97: 799-804
102. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 1995; 109: 516-23
103. Babyatsky MW, deBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol-And indomethacin-induced gastric injury in rats. Gastroenterology 1996; 110:489-97
104. Beck PL, Podolsky DK. Intestinal trefoil factor reduces the severity of chemotherapy-And radiotherapy-induced intestinal mucositis. Gastroenterology 1999; 116: A486
105. Play ford RJ, Marchbank T, Goodlad RA et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad SciUSA 1996; 93: 2137-2
106. Wright NA, Poulsom R, Stamp GVsI et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990; 162:279-84
107. Wright NA, Poulsom R, Stamp G et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-20
108. Itoh H, Tomita M, Uchino H et al. cDNA cloning of rat pS2 peptide and expression in acetic acid-induced colitis. BiochemJ 1996; 318: 939-44
109. Taupin DR, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK. The trefoil gene family are co-ordinately expressed immediate-early genes: EGF receptor-And MAP kinase-Depcndent interregulation. J Clin Invest 1999; 103: R31-8
110. Ogata H, Podolsky DK. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am J Physiol 1997; 273: G348-54
111. Podolsky DK, Lynch-Devaney K, Stow JL et al. Identification of human intestinal trefoil factor. Goblet-cell specific expression of a peptide targeted for apical secretion. J Biol Chem 1993:268:6694-702
112. Newton JL, Allen A, Wcstlcy BR, May FE. The human trefoil peptide, TFFl, is present in different molecular forms that arc intimately associated with mucus in normal stomach. Gut 2000; 46: 312-20
113. Hoffmann W. A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide. J Biol Chem 1988; 263: 7686-90
114. Hauser F, Hoffmann W. P-Domains as shuffled cysteine-rich modules in in integumentary mucin C.l (FIM-C. 1) from Xenopus laevis. J Biol Chem 1992; 267: 24620-4
115. Lefebvrc O, Chenard MP, Masson R et al. Gastric mucosa abnormalities in mice lacking the pS2 trefoil protein. Science 1996; 274: 259-62
116. Tomasetto C, Masson R, Linares JL et al. pS2/TFFl interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 2000; 118: 70-80
117. Cook GA, Familari M, Thim L, Giraud AS. The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Lett 1999; 456: 155-9
118. Tran CP, Cook GA, Yeomans ND, Thim L, Giraud AS. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 1999; 44: 636-42
119. Hoosein NM, Thim L, Jorgensen KH, Brattain MG. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Lett 1989; 247: 303-6
120. Thim L. A new family of growth factor-like peptides: Trefoií disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989; 250: 85-90
121. Kato K, Chen MC, Nguyen M, Lehmann FS, Podolsky DK, Soil AH. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures. Am J Physiol 1999; 276: Gl 105-16
122. Uchino H, Kataoka H, Itoh H, Hamasuna R, Koono M. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterology 2000; 118: 60-9
123. Carroll KM, Wong TT, Drabik DL, Chang EB. Differentiation of rat small intestinal epithelial cells by extracellular matrix. Am J Physiol 1988; 254: G355-60
124. Hahn U, Stallmach A, Hahn EG, Riecken EO. Basement membrane components are potent promoters of rat intestinal epithelial cell differentiation in vitro. Gastroenterology 1990;98:322-35
125. Olson AD, Pysher T, Bienkowski RS. Organization of intestinal epithelial cells into multicellular structures requires laminin and functional actin microfilaments. Exp Cell Res 1991; 192:543-9
126. Simo P, Simon-Assmann P, Arnold C, Kedinger M. Mesenchyme-mediated effect of dexamethasone on laminin in cocultures of embryonic gut epithelial cells and mesenchyme-Derived cells. J Cell Sci 1992; 101: 161-71
127. Moore R, Madara JL, MacLeod RJ. Enterocytes adhere preferentially to collagen IV in a differentially regulated divalent cation-Dependent manner. Am J Physiol 1994; 266: G1099-107
128. Turowski GA, Rashid Z, Hong F, Madri JA, Basson MD. Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Cancer Res 1994; 54: 5974-80
129. Vachon PH, Beaulieu JF. Extracellular helerolrimeric laminin promotes differentiation in human enterocytes. Am J Physiol 1995; 268: G857-67
130. Timpl R, Dziadck M. Structure, development, and molecular pathology of basement membranes. Int Rev Exp Pathol 1986; 29: 1-112
131. Laurie GW, Lcblond CP, Martin GR. Localization of type IV collagen, Laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes. J Cell Biol 1982; 95: 340-4
132. Quaroni A, Isselbachcr KJ, Ruoshlahti E. Fibronectin synthesis by epithelial crypt cells of rat small intestine. Proc Natl Acad Sci USA 1978; 75: 5548-52
133. Goke M, Zuk A, Podolsky DK. Regulation and function of extracellular matrix in intestinal epithelial restitution in vitro. Am J Physiol 1996; 271: G729-40
134. Hahn U, Schuppan D, Hahn EG, Merker HJ, Riecken EO. Intestinal cells produce basement membrane proteins in vitro. Gui 1987;28:S143-51
135. Simo P, Bouziges F, Lissitzky JC, Sorokin L, Kedinger M, Simon-Assmann P. Dual and asynchronous deposition of laminin chains at the epithelial- mesenchymal interface in the gut. Gastroenterology 1992; 102: 1835-45
136. Weiser MM, Sykes DE, Killen PD. Rat intestinal basement membrane synthesis. Epithelial versus non epithelial contributions. Lab Invest. 1990;62:325-30
137. Trier JS, Allan CH, Abrahamson DR, Hagen SJ. Epithelial basement membrane of mouse jejunum. Evidence for laminin turnover along the entire crypt-villus axis. J Clin Invest 1990; 86: 87-95
138. O'Keefe EJ, Payne RE, Russell N, Woodley DT Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol 1985; 85: 125-30
139. Sarret Y, Stamm C, Jullien D, Schmitt D. Keratinocyte migration is partially supported by the cell-binding domain of fibronectin and is RGDS-Dependent. J Invest Dermatol 1992; 99: 656-9
140. Basson MD, Modlin IM, Flynn SD, Jena BP, Madri JA. Independent modulation of enterocyte migration and proliferation by growth factors, matrix proteins, and pharmacologic agents in an in vitro model of mucosal healing. Surgery 1992; 112:299-307
141. Moore R, Madri J, Carlson S, Madara JL. Collagens facilitate epithelial migration in restitution of native Guinea pig intestinal epithelium. Gastroenterology 1992; 102: 119-30
142. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 1989; 58: 575-606
143. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-9
144. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64: 841-8
145. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79: 1005-13
146. Schuppan D, Schmid M, Somasundaram R et al. Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 1998; 114: 139-52
147. MacDonald TT, Pender SL. Proteolytic enzymes in inflammatory bowel disease. Inflam Bowel Dis 1998; 4: 157-64
148. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage met alloelastase (MMP-12), and tissue inhibitor of met alloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998; 152: 1005-14
149. Baugh MD, Perry MJ, Hollander AP et al. Matrix met alloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999; 117: 814-22
150. Louis E, Ribbens C, Godon A et al. Increased production of matrix met alloproteinase-3 and tissue inhibitor of met alloproteinase-1 by inflamed mucosa in inflammatory bowel disease. CHn Exp Immunol 2000; 120: 241-6
151. Sykes AP, Bhogal R, Brampton C et al. The effect of an inhibitor of matrix met alloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Ahment Pharmacol Ther 1999; 13: 1535-1542
152. Deane HW. Some electron microscopic observations on the lamina propria of the gut, with some comments on the close association of macrophages, plasma cells and eosinophils. AnatRecl964; 149:453-73
153. Donellan WL. The structure of the colonic mucosa. The epithelium and subepithelial reticulo-histiocytic complex. Gastroenterology 1965; 49: 496-514
154. Mahida YR, Galvin AM, Gray Tet al. Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol 1997; 109: 377-86
155. McAhndon ME, Gray T, Galvin A, Sewell HP, Podolsky DK, Mahida YR. Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa. Gastroenterology 1998; 115: 841-8
156. Mahida YR, Beltinger J, Makh S et al. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and-2. Am J Physiol 1997; 273: G1341-8
157. Powell DW, Mifliin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999; 277: Cl-9
158. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 1999; 277: C183-201
159. Graham MP, Diegelmann RF, Elson CO et al. Collagen content and types in the intestinal strictures of crohn's disease. Gastroenterology 1988; 94: 257-65
160. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen type III synthesis in fibroblasts isolated from strictures of patients with crohn's disease. Gastroenterology 1992; 102: 1920-9
161. Graham MF, Drucker DEM, Diegelmann RF, Elson CO. Collagen synthesis by human intestinal smooth muscle cells in cuhure. Gastroenterology 1987; 92: 400-5
162. Strong SA, Pizarro TT, Klein JS, Cominelli F, Fiocchi C. Proinffammatory cytokines differentially modulate their own expression in human intestinal mucosal mesenchymal cells. Gastroenterology 1998; 114: 1244-56
163. JobsonTM, Bilhngton CK, Hall IP. Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inffammation. J Clin Invest 1998; 101:2650-7
164. Plateroti M, Rubin DC, Duluc I et al. Subepithelial fibroblast cell lines from different levels of gut axis display regional characteristics. Am J Physiol 1998; 274: G945-54
165. Munz B, Smola H, Engelhardt F et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999; 18: 5205-15
166. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909-22
167. Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA, McKinley MJ. A preliminary study of growth hormone therapy for crohn's disease. N Engl J Med 2000; 342: 1633-7
168. Ali lU, Schriml LM, Dean M. Mutational spectra of PTEN/MMACl gene: A tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999; 91: 1922-32
169. Rudolph KL, Chang S, Lee HW et al. Longevity, stress response, and cancer in aging telomerase-Deficient mice. Cell 1999; 96: 701-12
170. Kagnoff MF. Current concepts in mucosal immunity. III. Ontogeny and function of y/5 T cell in the intestine. Am J Physiol 1998; 274: G455-8
171. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998; 115: 182-205